LAG3 and autoimmune disease: While the binding of these two activation antigens negatively regulates activated T cells, LAG-3 alone may work as a negative regulator to prevent the exacerbation of a variety of autoimmunity diseases, and has expected to be a promising therapeutic target in autoimmune diseases 54, 55.